title: Scarring alopecia associated with use of the epidermal growth factor receptor inhibitor gefitinib.
authors.forename: Jeffrey C
authors.initials: JC
authors.lastname: Donovan
authors.forename: Danny M
authors.initials: DM
authors.lastname: Ghazarian
authors.forename: James C
authors.initials: JC
authors.lastname: Shaw
mesh_terms: D000368:Aged; D000505:Alopecia / Q000139:chemically induced* / Q000473:pathology; D001707:Biopsy, Needle; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000473:pathology; D002921:Cicatrix / Q000139:chemically induced* / Q000473:pathology; D018450:Disease Progression; D066246:ErbB Receptors / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D017809:Fatal Outcome; D000077156:Gefitinib; D006801:Humans; D007150:Immunohistochemistry; D008175:Lung Neoplasms / Q000188:drug therapy / Q000473:pathology; D008297:Male; D011799:Quinazolines / Q000009:adverse effects* / Q000627:therapeutic use; D018570:Risk Assessment
chemical_list: D011799:Quinazolines; D066246:ErbB Receptors; D000077156:Gefitinib